Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 1
2018 3
2019 1
2020 1
2021 6
2022 5
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer.
Mendiola M, Heredia-Soto V, Ruz-Caracuel I, Baillo A, Ramon-Patino JL, Escudero FJ, Miguel M, Pelaez-Garcia A, Hernandez A, Feliu J, Hardisson D, Redondo A. Mendiola M, et al. Among authors: heredia soto v. Int J Mol Sci. 2023 Sep 23;24(19):14468. doi: 10.3390/ijms241914468. Int J Mol Sci. 2023. PMID: 37833916 Free PMC article.
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
Pesántez D, Ten Hoorn S, Machado I, García-Albéniz X, Rodríguez-Salas N, Heredia-Soto V, Viñal D, Pericay C, García-Carbonero R, Losa F, Alonso V, Vera R, Feliu Batlle J, Gallego J, Salud A, Nogué M, Layos L, Montagut C, Capdevila J, Vermeulen L, Maurel J, Fernandez-Martos C. Pesántez D, et al. Among authors: heredia soto v. J Natl Cancer Inst. 2023 Dec 6;115(12):1497-1505. doi: 10.1093/jnci/djad120. J Natl Cancer Inst. 2023. PMID: 37405857 Clinical Trial.
Can we avoid the toxicity of chemotherapy in elderly cancer patients?
Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, Molina-Garrido MJ. Feliu J, et al. Among authors: heredia soto v. Crit Rev Oncol Hematol. 2018 Nov;131:16-23. doi: 10.1016/j.critrevonc.2018.08.008. Epub 2018 Aug 28. Crit Rev Oncol Hematol. 2018. PMID: 30293701 Review.
Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma.
Jungen SH, Noti L, Christe L, Galvan JA, Zlobec I, Müller MD, Imboden S, Siegenthaler F, Carlson JW, Pellinen T, Heredia-Soto V, Ruz-Caracuel I, Hardisson D, Redondo A, Mendiola M, Rau TT. Jungen SH, et al. Among authors: heredia soto v. Front Med (Lausanne). 2023 Mar 23;10:1110529. doi: 10.3389/fmed.2023.1110529. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37035329 Free PMC article.
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression.
Montero-Calle A, López-Janeiro Á, Mendes ML, Perez-Hernandez D, Echevarría I, Ruz-Caracuel I, Heredia-Soto V, Mendiola M, Hardisson D, Argüeso P, Peláez-García A, Guzman-Aranguez A, Barderas R. Montero-Calle A, et al. Among authors: heredia soto v. Cell Oncol (Dordr). 2023 Jun;46(3):697-715. doi: 10.1007/s13402-023-00778-w. Epub 2023 Feb 6. Cell Oncol (Dordr). 2023. PMID: 36745330 Free PMC article.
Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancer.
Mendiola M, Pellinen T, Ramon-Patino JL, Berjon A, Bruck O, Heredia-Soto V, Turkki R, Escudero J, Hemmes A, Garcia de la Calle LE, Crespo R, Gallego A, Hernandez A, Feliu J, Redondo A. Mendiola M, et al. Among authors: heredia soto v. Mod Pathol. 2022 Feb;35(2):256-265. doi: 10.1038/s41379-021-00930-7. Epub 2021 Oct 12. Mod Pathol. 2022. PMID: 34642425 Free article.
Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
Ramon-Patino JL, Ruz-Caracuel I, Heredia-Soto V, Garcia de la Calle LE, Zagidullin B, Wang Y, Berjon A, Lopez-Janeiro A, Miguel M, Escudero J, Gallego A, Castelo B, Yebenes L, Hernandez A, Feliu J, Pelaez-García A, Tang J, Hardisson D, Mendiola M, Redondo A. Ramon-Patino JL, et al. Among authors: heredia soto v. Cancers (Basel). 2022 Feb 12;14(4):912. doi: 10.3390/cancers14040912. Cancers (Basel). 2022. PMID: 35205661 Free PMC article.
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer.
Gallego A, Mendiola M, Hernando B, Berjon A, Cadiz A, Chaves-Urbano B, Heredia-Soto V, Spagnolo E, Hernández Gutiérrez A, Hardisson D, Macintyre G, Redondo A, Garcia MJ. Gallego A, et al. Among authors: heredia soto v. Int J Gynecol Cancer. 2022 Aug 1;32(8):1009-1016. doi: 10.1136/ijgc-2022-003353. Int J Gynecol Cancer. 2022. PMID: 35437272
24 results